Tender detail

Conclusion of a non-exclusive rebate agreement for abobotulinumtoxin A medicines for 2026–2028

Summary

DAK-Gesundheit is procuring non-exclusive pharmaceutical rebate agreements for the active substance botulinum toxin type A, limited to abobotulinum (ATC M03AX21). The agreements cover medicines identified by the supplier and run from 1 December 2026 to 30 November 2028, or end earlier when a new exclusive agreement takes effect.

Reference number
fc156a7a-9699-4692-b2da-9b63c2c72ba5
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.